key: cord-0956321-p6qyosn9 authors: Sills, Eric Scott; Wood, Samuel Horace title: An Experimental Model for Peri-conceptual COVID-19 Pregnancy Loss and Proposed Interventions to Optimize Outcomes date: 2020-11-10 journal: Int J Mol Cell Med DOI: 10.22088/ijmcm.bums.9.3.180 sha: 838f3d54181fa8c457c6502526ccecaa0e17fec6 doc_id: 956321 cord_uid: p6qyosn9 Reports appear to give reassurance that vertical transmission near term is unlikely, but risks of incidental SARS-CoV-2 infection during fertility treatments, at embryo implantation, or in the first trimester remain unknown. If early pregnancy sequela in the current COVID-19 pandemic are modeled from the 2004 Coronavirus outbreak data, then SARS-CoV-2 infection proximate to blastocyst nidation is likely to cause implantation failure or spontaneous abortion. Our model explains why this outcome is less attributable to virus-associated maternal pulmonary distress and instead derives from systemic inflammation and interference with trophectoderm-endometrium molecular signaling required for implantation. COVID-19 is often accompanied by high levels of IL-6, IL-8, TNF-alpha and other cytokines, a process implicated in pulmonary collapse and systemic organ failure. Yet when regarded in an early reproductive context, this “cytokine storm” of COVID-19 triggers a pro-coagulative state hostile to normal in utero blastocyst/fetal development. Evidence from obstetrics is accumulating to show that mothers with SARS-CoV-2 deliver placentas with abnormal interstitial villi fibrin deposits, diffuse infarcts, and hemangiomatous changes. This model classifies such lesions as permissive at term but catastrophic near embryo implantation or early first trimester pregnancy. Clinical experience with recurrent pregnancy loss offers workable interventions to address this challenge, but success will depend on prompt and accurate SARS-CoV-2 diagnosis. Although no professional guidelines currently exist for SARS-CoV-2 in early pregnancy, this model would warrant a high-risk designation for such cases; these patients should receive priority access to screening and treatment resources. Although SARS-CoV-2 is not a descendent of SARS-CoV, the two viruses are sufficiently similar that their shared evolutionary histories are informative (4) . As efforts to develop an effective vaccine, treatment, and rapid screening for COVID-19 are redoubled, increased appreciation of underlying cytokine processes is gaining momentum. Perhaps the most intriguing of these involves a type of virus-induced hypofibrinolysis which brings the most relevance to the early reproductive sequence. While most COVID-19 research has focused on pulmonary angiotensin-converting enzyme 2 (ACE-2) receptor, ACE-2 mRNA from endometrium localizes this receptor to the uterine interior as well (5) . Our hypothesis incorporates data from endometrial samples assessed by immunoassay throughout the menstrual cycle ( Figure 1 ). Such cells obtained by transcervical This balance is recalibrated in pregnancy as a putative fetal protective effect, although such permissive immunotolerance comes with increased maternal susceptibility to pathogens (9) (10) (11) . COVID-19 is characterized by augmented IFN-γ and IL-1β, IL-4, IL-10 and IFN-γ production (12) . Preferential stimulation of Th1 immunity is often triggered in COVID-19 disease, yielding a sharp cytokine uptick for at least two weeks after initial infection (13) . Interestingly, elevated IL-6 levels have been linked to increased mortality in COVID-19 (9, 14) . The 2019-new coronavirus epidemic: Evidence for virus evolution Transmission dynamics and evolutionary history of 2019-nCoV The first two cases of 2019-nCoV in Italy: Where they come from Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensinconverting enzyme type 2 are expressed in the human endometrium Cytokines: Important for implantation? Protective Effect of Chlorpromazine against Endotoxin-Induced Abortion Inhibition of pregnancy viability in mice following IL-2 administration Coronavirus disease 2019 (COVID-19) pandemic and pregnancy Peripheral blood cytokine profiling during pregnancy and post-partum periods Influenza vaccination during pregnancy and its usefulness to mothers and their young infants Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID Delivery in pregnant women infected with SARS-CoV-2: A fast review Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: A systematic review of 441 cases (preprint) Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Effects of Coronavirus Disease 2019 (COVID-19) on Maternal, Perinatal and Neonatal Outcomes: A Systematic Review of 266 Pregnancies. MedRxiv (preprint) May Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia Coronavirus disease 2019 in pregnant women: a report based on 116 cases Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment Modulation of Decidual Macrophage Polarization by Macrophage Colony-Stimulating Factor Derived from First-Trimester Decidual Cells: Implication in Preeclampsia Local regulation of implantation at the human fetal-maternal interface Prominent changes in blood coagulation of patients with SARS-CoV-2 infection Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Plasminogen improves lung lesions and hypoxemia in patients with COVID-19 Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? Effects of chloroquine on viral infections: an old drug against today's diseases Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for? Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice A mysterious blood-clotting complication is killing coronavirus patients COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure The authors declare no conflict of interest.